Now Is Not The Time To Buy Celanese Stock

Celanese Faces Significant Challenges Amid Deteriorating Demand

Celanese (NYSE: CE), a prominent player in the chemicals industry, is grappling with substantial challenges as customer demand continues to decline. This downward trend has negatively impacted both sales volumes and prices, particularly in key markets such as automotive, construction, and industrial applications. The company anticipates these difficult conditions to persist in the short term, which has already led to severe financial repercussions. In the fourth quarter, Celanese reported a significant loss of $1.4 billion on revenue of $2.4 billion, highlighting the magnitude of the struggle. The immediate aftermath of this earnings announcement saw CE stock plummet by 21%, further underscoring investor concern.

Despite its recent decline, CE stock appears unattractive at its current price of around $55. While the stock may seem undervalued compared to broader market benchmarks, a closer examination of its operating performance and financial condition reveals several red flags. This analysis evaluates Celanese’s performance across key parameters such as growth, profitability, financial stability, and downturn resilience, all of which point to significant weaknesses that make the stock a risky investment.

Celanese’s Valuation: A Mixed Picture

On the surface, Celanese’s valuation metrics suggest that the stock might be undervalued compared to the broader market. For instance, the company’s price-to-sales (P/S) ratio of 0.7 is significantly lower than the S&P 500’s 3.1. Similarly, its price-to-operating income (P/EBIT) ratio of 7.0 and price-to-earnings (P/E) ratio of 6.0 are also well below the S&P 500’s ratios of 24.4 in both cases. These metrics might lead some investors to believe that Celanese is a bargain. However, it is crucial to delve deeper into the company’s financial health and operating performance to understand why the stock might not be as attractive as it seems.

While Celanese’s valuation appears cheap, it is essential to consider the broader context of the company’s financial struggles and market conditions. The stock’s low valuation is likely a reflection of its underlying weaknesses, which include declining revenues, poor financial stability, and lackluster profitability. Investors must consider whether the stock’s low price is justified or if it presents a false sense of value.

Revenue Growth: A Mixed Bag

Celanese’s revenue growth over recent years presents a mixed picture. While the company has seen its top line grow at an average rate of 25.8% over the last three years, this growth has not been consistent. In the last 12 months, revenues have actually declined by 2.2%, from $11 billion to $10 billion. This contrasts sharply with the S&P 500’s revenue growth of 5.6% over the same period. The most recent quarter also saw a 2.8% decline in revenues, from $2.7 billion to $2.6 billion, further highlighting the company’s struggles.

These revenue trends raise concerns about Celanese’s ability to maintain growth in the face of weakening demand and market headwinds. While the company has shown some growth in the past, its recent performance suggests that it is facing significant challenges in sustaining momentum. This inconsistency in revenue growth is a critical factor for investors to consider when evaluating the stock’s potential.

Profitability: A Median Performer

Celanese’s profitability metrics reveal a company that is performing around the median level for its industry. Over the last four quarters, the company reported an operating income of $1.1 billion, which translates to a moderate operating margin of 10.5%. This figure is slightly below the S&P 500’s operating margin of 12.6%. Similarly, Celanese’s operating cash flow (OCF) over this period was $1.3 billion, resulting in an OCF-to-sales ratio of 12.4%, which is also slightly lower than the S&P 500’s 14.4%.

While Celanese’s profitability is not significantly below the broader market, it is also not strong enough to offset its other weaknesses. The company’s margins are neither exceptionally high nor alarmingly low, but they do suggest that Celanese is not outperforming its peers in terms of profitability. This mediocre performance adds to the concerns surrounding the stock’s attractiveness.

Financial Stability: A Cause for Concern

One of the most significant red flags for Celanese is its financial stability. The company’s balance sheet is heavily burdened by debt, with a total debt of $13 billion as of the most recent quarter. This figure is particularly concerning when compared to the company’s market capitalization of $6.0 billion, as of February 19, 2025. This results in a debt-to-equity ratio of 171.7%, which is vastly higher than the S&P 500’s average of 19.7%. A high debt-to-equity ratio is generally a sign of financial instability, as it indicates that the company is relying heavily on debt to finance its operations.

Furthermore, Celanese’s cash reserves are alarmingly low. The company’s cash and cash equivalents amount to $813 million, which represents only 3.1% of its total assets of $26 billion. This cash-to-assets ratio is significantly lower than the S&P 500’s average of 14.1%. With such limited cash reserves, Celanese may face difficulties in meeting its financial obligations or investing in growth opportunities, especially during times of economic uncertainty.

Downturn Resilience: A History of Underperformance

Celanese’s stock has historically performed poorly during economic downturns, raising concerns about its resilience in challenging market conditions. During the COVID-19 recession, for instance, CE stock fell by 51.7%, compared to a 33.9% decline for the S&P 500. The stock took 876 days to recover to its pre-COVID peak, whereas the S&P 500 rebounded in just 148 days. This prolonged recovery period highlights Celanese’s vulnerability during economic crises.

Similarly, during the Great Recession of 2007-2009, CE stock fell by 84.9%, significantly outpacing the S&P 500’s decline of 56.8%. While the stock eventually recovered to its pre-recession peak, it took 1,522 days to do so, which is slightly longer than the S&P 500’s recovery period of 1,480 days. This historical underperformance during downturns suggests that Celanese’s stock is not only risky but also less likely to provide a safe haven for investors during economic turmoil.

Conclusion: Celanese Stock is a Risky Investment

In summary, Celanese’s performance across key parameters such as growth, profitability, financial stability, and downturn resilience paints a picture of a company in distress. While its low valuation might seem appealing at first glance, the stock’s underlying weaknesses make it an unattractive investment. The company’s declining revenues, mediocre profitability, and poor financial stability are significant concerns that outweigh its low valuation.

Furthermore, Celanese’s history of underperformance during economic downturns adds another layer of risk for investors. The stock’s high debt levels and limited cash reserves make it particularly vulnerable to market volatility and economic uncertainties. As such, it is crucial for investors to exercise caution and avoid CE stock until the company demonstrates meaningful improvement in its financial health and operating performance.

For investors seeking more resilient investment opportunities, the Trefis Reinforced Value (RV) Portfolio offers a promising alternative. This portfolio has consistently outperformed broader market benchmarks by balancing large-, mid-, and small-cap stocks, providing a responsive strategy to capitalize on favorable market conditions while minimizing losses during downturns. With its strong track record, the RV Portfolio is an attractive option for those looking to build a more robust investment strategy.